Evidence map›Paper›PMID 28548658›Full record

ArticleThe ISME journal2017

Distinctive microbiomes and metabolites linked with weight loss after gastric bypass, but not gastric banding.

Zehra Esra Ilhan, John K DiBaise, Nancy G Isern, David W Hoyt, Andrew K Marcus, Dae-Wook Kang, Michael D Crowell, Bruce E Rittmann, Rosa Krajmalnik-Brown

Open access · bronzeAbstract read
In one paragraph

Article in The ISME journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 4 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 4 syntheses or guidelines pooled it, 141 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. [Research progress of probiotics regulating intestinal micro-ecological environment in obese patients after bariatric surgery].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2024
    Review
  20. Review

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zehra Esra IlhanBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, AZ, USA.
John K DiBaiseMayo Clinic, Division of Gastroenterology, Scottsdale, AZ, USA.
Nancy G IsernWilliam R. Wiley Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.
David W HoytWilliam R. Wiley Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, WA, USA.ORCID 0000-0002-2857-719X
Andrew K MarcusBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, AZ, USA.
Dae-Wook KangBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, AZ, USA.
Michael D CrowellMayo Clinic, Division of Gastroenterology, Scottsdale, AZ, USA.
Bruce E RittmannBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, AZ, USA.
Rosa Krajmalnik-BrownBiodesign Swette Center for Environmental Biotechnology, Arizona State University, Tempe, AZ, USA.
Arizona State University · USMayo Clinic in Arizona · USPacific Northwest National Laboratory · US

Funding

Role of Human Intestinal Microbiota on Success of Surgical Weight Loss ProceduresR01DK090379 · NIDDK · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI DIBAISE, JOHN K., KRAJMALNIK-BROWN, ROSA · 2011 to 2014
$1.9M
NIDDK NIH HHS R01 DK090379
6 · The paper itself

Abstract

Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) are anatomically different bariatric operations. RYGB achieves greater weight loss compared with LAGB. Changes in the gut microbiome have been documented after RYGB, but not LAGB, and the microbial contribution to sustainable surgical weight loss warrants further evaluation. We hypothesized that RYGB imposes greater changes on the microbiota and its metabolism than LAGB, and that the altered microbiota may contribute to greater weight loss. Using multi-omic approaches, we analyzed fecal microbial community structure and metabolites of pre-bariatric surgery morbidly obese (PreB-Ob), normal weight (NW), post-RYGB, and post-LAGB participants. RYGB microbiomes were significantly different from those from NW, LAGB and PreB-Ob. Microbiome differences between RYGB and PreB-Ob populations were mirrored in their metabolomes. Diversity was higher in RYGB compared with LAGB, possibly because of an increase in the abundance of facultative anaerobic, bile-tolerant and acid-sensible microorganisms in the former. Possibly because of lower gastric acid exposure, phylotypes from the oral cavity, such as Escherichia, Veillonella and Streptococcus, were in greater abundance in the RYGB group, and their abundances positively correlated with percent excess weight loss. Many of these post-RYGB microorganisms are capable of amino-acid fermentation. Amino-acid and carbohydrate fermentation products-isovalerate, isobutyrate, butyrate and propionate-were prevalent in RYGB participants, but not in LAGB participants. RYGB resulted in greater alteration of the gut microbiome and metabolome than LAGB, and RYGB group exhibited unique microbiome composed of many amino-acid fermenters, compared with nonsurgical controls.

Indexed as

Gastrointestinal MicrobiomeAdultAgedBacteriaFecesFemaleGastric BypassGastroplastyHumansMaleMiddle AgedObesity, MorbidWeight LossYoung Adult

Identifiers

PMID28548658
PMCPMC5563958
OpenAlexW2618161090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.